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Abstract
After 40 years of deriving metric values for health status or health-related quality of life, the effective quantification of
subjective health outcomes is still a challenge. Here, two of the best measurement tools, the discrete choice and the Rasch
model, are combined to create a new model for deriving health values. First, existing techniques to value health states are
briefly discussed followed by a reflection on the recent revival of interest in patients’ experience with regard to their
possible role in health measurement. Subsequently, three basic principles for valid health measurement are reviewed,
namely unidimensionality, interval level, and invariance. In the main section, the basic operation of measurement is then
discussed in the framework of probabilistic discrete choice analysis (random utility model) and the psychometric Rasch
model. It is then shown how combining the main features of these two models yields an integrated measurement model,
called the multi-attribute preference response (MAPR) model, which is introduced here. This new model transforms
subjective individual rank data into a metric scale using responses from patients who have experienced certain health
states. Its measurement mechanism largely prevents biases such as adaptation and coping. Several extensions of the MAPR
model are presented. The MAPR model can be applied to a wide range of research problems. If extended with the self-
selection of relevant health domains for the individual patient, this model will be more valid than existing valuation
techniques.
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Introduction
The measurement of health, which is defined as assigning
meaningful numbers to an individual’s health status, has
proliferated ever since the World Health Organization (WHO)
provided its definition of health in 1946 [1]. It wasn’t until 1970
that Fanshel and Bush introduced the first instrument that was
able to capture an individual’s health state in a single metric value
[2]. Access to single metric values for health states is advantageous
as these can be used in health outcomes research, disease modeling
studies, economic evaluations, and to monitor the health status of
patient groups in the general community. Often the values for
health states are expanded by combining it with the duration of
these states to obtain health summary measures. A well known
example of such a summary measure is the disability-adjusted life
years (DALYs) approach that is being used by the WHO to
compare different countries with one another on diverse aspects of
health. Health economists often apply a rather comparable health
summary measure, namely the quality-adjusted life year (QALY).
To quantify health states, these must be described and classified
in terms of seriousness and assigned meaningful values (variously
called utilities, strength of preference, index, or weights). The first
step is thus to clarify the concept of health status. Essentially an
umbrella concept, it covers independent health domains that
together capture the not yet well defined notion of health-related
quality of life (HRQoL). The second step is to assign a value to the
health-state description by means of an appropriate measurement
procedure. In the past, several measurement models have been
developed to quantify subjective phenomena and some of these
models have found their way into the valuation of health states.
Although the scientific enterprise of measuring health states has
been going on for about 40 years, there are still concerns about
validity.
The aim of this paper is to forge a linkage between two
prominent measurement models to create a single general model
that – at least in principle – resolves many of the problems posed
by widely used but inferior valuation techniques. This new
measurement framework for deriving health-state values is called
the multi-attribute preference response (MAPR) model. It
combines the characteristics of hypothetical health states with a
respondent’s health-status characteristics to quantify both the
hypothetical states as well as the location of the patients’ s state. In
theory, this new model even allows individuals to choose the
attributes (i.e., health domains) describing their health states. A
health measurement model with such potential flexibility is
unprecedented.
The first section of the paper presents some concerns about the
validity of current health-state valuation techniques followed by a
section about the basic measurement principles of subjective
phenomena (such a health). The next section explains the
probabilistic discrete choice model and expands on its relationship
to measurement models used in economics and psychology. The
subsequent section sketches the history of the Rasch model and
summarizes its underlying theory. Finally, the merits of integrating
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these two measurement models into the MAPR model are
discussed. All examples and suggestions in this article apply to
health-state valuation. It should be kept in mind that because the
MAPR model is very general, it can also be applied in a number of
other fields where the goal is to quantify other subjective
phenomena.
Existing Valuation Techniques
The standard gamble (SG) and time trade-off (TTO) are
frequently used to assign values to health states. The former
emerged from the field of economics, the latter from the area of
operations research [3,4]. SG, for years the gold standard, was
developed under the expected utility theory of von Neumann and
Morgenstern [3]. But as experience shows, assumptions underlying
this theory were systematically violated by human behavior. In
general, people have difficulty dealing with probabilities and may
have an aversion to taking risk. As an alternative, Torrance and
colleagues developed TTO, which is simpler to administer than
SG. The main drawback of TTO is that the relationship between
a health state, its duration, and its value is collapsed into a single
measure. The problem is that this requires the values for health
states to be independent of the duration of these states. Health-
state values have also been derived by another technique, the
visual analogue scale (VAS), which stems from the field of
psychology [5]. Unfortunately, all of these conventional measure-
ment techniques (SG, TTO, VAS) have theoretical and empirical
drawbacks when used to value health states. With the possible
exception of the VAS, they put a large cognitive burden on the
respondents by demanding a relatively high degree of abstract
reasoning [6]. The person trade-off (PTO) is another technique
that has been used mainly in the area of policy making [7]. This
technique was named by Nord [8], but the technique itself was
applied earlier by Patrick et al. [9]. The PTO asks respondents to
answer from the perspective of a social decision-maker considering
alternative policy choices.
The currently dominant valuation technique for quantifying
health states, certainly in the field of health economics, is the time
trade-off (TTO). It may be intuitively appealing for three reasons.
First, it seems to reflect the actual medical situation. Second, it
shows some correspondence to the general health-outcome
framework (since the TTO is essentially a QALY equivalence
statement). And third, it is grounded in economic thinking (the
trade-off principle). Nevertheless, compelling arguments against
the TTO have been raised by several authors [10,11,12,13,14]. In
fact, TTO seems to be associated with many problems: practical
(difficult for people to perform), theoretical (axiomatic violations,
problems in dealing with states worse than dead), and biases (time
preference). From a measurement perspective, the TTO technique
has been criticized for its susceptibility to framing issues (e.g.,
duration of the time frame, indifference procedure, states worse
than dead). The same holds for the recently introduced technique
known as lead-time TTO [15].
Patients versus General Population
Conventionally, values for the health states used in economic
evaluations are derived from a representative community sample
[16], or in the case of the DALY approach, values for disease states
were derived from medical experts [17]. Besides asserting that a
sample of the general population is a reflection of the average
taxpayer, which is considered fair grounds for arriving at resource
allocation, other arguments are put forward. For example, it has
been noted that patients may adapt to their health state over a
period of time. As a result, they may assign higher values to their
own poor health state. Patients may also strategically underrate the
quality of their health state, knowing they will directly benefit from
doing so (e.g., certain patient groups may be considered as more
relevant by policy makers, or effects in cost-effectiveness studies
may show more favorable results). The proposition held in this
paper is that while adaptation is a real phenomenon, this effect can
largely be reduced and eventually eliminated if the health-state
values are derived in a fitting measurement framework. Moreover,
it is reasonable to assume that healthy people may be inadequately
informed or lack the imagination to make an appropriate
judgment on the impact of severe health states. This is one of
the reasons why researchers in the field of HRQoL are engaged in
a debate about which values are more valid [18,19]. Many
researchers assert that individuals are the best judges of their own
health status [20]. Therefore, in a health-care context, it is sensible
to defend the position that, from a validity perspective, it is the
patient’s judgment that should be elicited in order to arrive at
health-state values, not that of a sample of unaffected members of
the general population. This explains the rise of the so-called
patient-reported outcome measurement (PROMs) movement [21].
Voices from another area have also stressed that such assessments




There are theoretical and methodological differences between
the direct valuation techniques (SG, TTO, VAS) and indirect
(latent) measurement models such as probabilistic discrete choice
(DC; see next section). But they all assume that individuals possess
implicit preferences for health states that range from good to bad.
And all of the models maintain that it should be possible to reveal
these preferences and express them quantitatively. Accordingly,
differences between health states should reflect the increments of
difference in severity of these states. For that reason, informative
(i.e., metric) outcome measures should be at least at the interval
level (cardinal data). This means that measures should lie on a
continuous scale, whereby the differences between values would
reflect true differences (e.g., if a patient’s score increases from 40 to
60, this increase is the same as from 70 to 90). To arrive at health-
state values with these qualities, two other basic measurement
principles should be fulfilled, namely unidimensionality and
invariance.
Unidimensionality
The overall goal is to use health-state values for computational
procedures (e.g., computing QALYs, Markov modeling). For that
reason, informative (i.e., metric) outcome measures should be at
least at the interval level. This implies positioning the values on an
underlying unidimensional scale ranging from the worst health
state to the best one. An (implicit) assumption made in the field of
health-state valuation is that, in general, individuals evaluate
health states similarly, which permits the aggregation of individual
valuations to arrive at group or societal values. Specific analyses
can be applied to find empirical evidence that health-state values
represent a unidimensional structure. An early application of the
statistical singular value decomposition routine compared TTO
and VAS valuation data. The results showed a clear two-
dimensional structure for the TTO [24]. Heterogonous responses
(or even distinct response structures) by individuals may indicate
that the phenomenon under study (health states) is not character-
ized as unidimensional or that a certain valuation technique is less
appropriate for the task, since it may not fulfill the need for
Health Measurement Model
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unidimensional responses. Therefore, it is important to determine
how similar individuals’ judgments (inter-rater reliability) actually
are.
Invariance
Invariance is a critical prerequisite for fundamental measure-
ment (see section: Rasch model). It means that the outcome of
judgments between two (or more) health states should not
dependent on which group of respondents performed the
assessments. The resulting judgments among health states should
also be independent of the set of health states being assessed [25].
In the setting of health-state valuation the invariance principle
appears to be closely related to the unidimensionality requirement.
Rasch models embody the invariance principle. Their formal
structure permits algebraic separation of the person and health-
state parameters. Specifically, the person parameter can be
eliminated during the process of statistical estimation of the
health-state parameters. Not surprisingly, the invariance principle
is a key characteristic of measurement in physics [25].
Discrete Choice Model
Background
Modern probabilistic discrete choice (DC) models, which come
from econometrics, build upon the work of McFadden, the 2000
Nobel Prize laureate in economics [26]. DC models encompass a
variety of experimental design techniques, data collection proce-
dures, and statistical procedures that can be used to predict the
choices that individuals will make between alternatives (e.g., health
states). These techniques are applicable when individuals have the
ability to choose between two or more distinct (‘discrete’)
alternatives.
In the mid-1960s McFadden was working with a graduate
student, Phoebe Cottingham, trying to analyze data on freeway
routing decisions as a way to study economic decision-making
behavior. He developed the first version of what he called the
‘conditional multinomial logistic model’ (also known as the
multinomial logistic model and conditional logistic model).
McFadden proposed an econometric model in which the utilities
of alternatives depend on utilities assigned to their attributes, such
as construction cost, route length, and areas of parkland and open
space taken up [27]. He developed a computer program that
allowed him to estimate this probabilistic model, which was based
on an axiomatic theory of choice behavior developed by the
mathematical psychologist Luce [28].
The DC strategy was conceived in transport economics and
later disseminated into other research fields, especially marketing.
There, DC modeling was applied to analyze behavior that could
be observed in real market contexts. Instead of modeling the
choices people actually make in empirical settings, Louviere and
others started to model the choices made by individuals in
carefully constructed experimental studies [29]. This entailed
presenting the participants with profiles containing features of
hypothetical products. Originally, these profiles were known as
simulated choice situations, but later they were called discrete
choice experiments (DCEs). So, instead of modeling actual
choices, as McFadden had with the revealed preferences
approach, Louviere modeled choices made in experimental studies
with the stated preferences approach. This new approach also
made it possible to predict values for alternatives that could not be
judged in the real world. More recently, DC models have been
used as an alternative way to derive people’s values for health
states [30,31,32].
Measurement Model
The statistical literature classifies DC models among the
probabilistic choice models that are grounded in modern
measurement theory and consistent with economic theory (e.g.,
the random utility model) [33]. What all DC models have in
common is that they can establish the relative merit of one
phenomenon with respect to others. If the phenomena are
characterized by specific attributes or domains with certain levels,
extended DC models such as McFaddens’ model would permit
estimating the relative importance of the attributes and their
associated levels. DC modeling has good prospects for health-state
valuation [32,34,35,36,37,38]. Moreover, DC models have a
practical advantage: when conducting DCEs, health states may be
evaluated in a self-completion format. The scope for valuation
research is thereby widened. Most TTO protocols for deriving
values for preference-based health-state instruments are interview-
er-assisted, as studies have clearly showed that self-completion is
not feasible or leads to inaccurate results [39]. The simplicity of
DC tasks, however, facilitates web-based surveys [38].
Discrimination mechanism. The modern measurement
theory inherent in DC models builds upon the early work and
basic principles of Thurstone’s Law of Comparative Judgment
(LCJ) [40,41]. In fact, the class of choice- and rank-based models,
with its lengthy history (1927 to the present), is one of the few areas
in the social and behavioral sciences that has a strong underlying
theory. It was Thurstone who introduced the well-known random
utility model (RUM), although he used different notation and
other terminology. The use of Thurstone’s model based on paired
comparisons to estimate health-state values was first proposed by
Fanshel and Bush [2] in one of the earliest examples of a
composed QALY index model.
In Thurstone’s terminology, choices are mediated by a
‘discriminal process’. He defined this as the process by which an
organism identifies, distinguishes, or reacts to stimuli. Consider the
theoretical distributions of the discriminal process for any two
objects (paired comparisons), like two different health states s and t.
In the LCJ model, the standard deviation of the distribution
associated with a given health state is called the discriminal
dispersion (or variance, in modern scientific language) of that
health state. Discriminal dispersions may differ for different health
states.
Let vs and vt correspond to the scale values of the two health
states. The difference (vs–vt) is measured in units of discriminal









where ss, st denotes the discriminal dispersions of the two health
states s and t, rst denotes the correlation between the pairs of
discriminal processes s and t, and zst is the unit normal deviate
corresponding to the theoretical proportion of times health state s
is judged greater than health state t. The difference is normally







, which reflects the standard deviation of the
difference between two normal distributions. In its most basic form
(Case V) the model can be represented as vs{vt~zst, for which
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where W is the cumulative normal distribution with mean zero and
variance unity.
The discrimination mechanism underlying the LCJ is an
extension of the ‘just noticeable difference’ that played a major
role in early psychophysical research, as initiated by Fechner
(1801–1887) and Weber (1795–1878) in Germany. Later on
similar discrimination mechanisms were embedded in ‘signal
detection theory’, which was used by psychologists to measure the
way people make decisions under conditions of uncertainty. Much
of the early work in this research field was done by radar
researchers [42].
Random utility model. Thurstone proposed that perceived
physical phenomena or subjective concepts (e.g., health states,
treatment outcomes, process characteristics) can be expressed as
that a respondent r has a latent value (utility) for state s, Urs, which
includes a systematic component and an error term (This is equal
to the fundamental idea of true score theory or classical test theory.
The latter also consists of an observed score with two components,
namely the true score and an error term. It too summarizes
different health domains by combining the scores on several
items.):
Urs~vszers ð3Þ
Here, v is the measurable component and is not determined by
characteristics of the respondents. In other words, a given health
state has the same expected value across all respondents. The
assumption in the model proposed by Thurstone is that e is
normally distributed. This assumption yields the probit model.
The choice probability is Prs=Pr(Urs.Urt, all t not equal to s),
which depends on the difference in value, not on its absolute level.
The fact that only differences in value matter has implications for
the identification of this model and all its derivates. In particular, it
means that the only parameters that can be estimated are those
that capture differences across alternatives.
So, in Thurstone’s LCJ, the perceived value of a health state
equals its objective level plus a random error. The probability that
one health state is judged better than another is the probability
that this alternative has the higher perceived value. When the
perceived values are interpreted as levels of satisfaction, HRQoL,
or utility, this can be interpreted as a model for economic choice in
which utility is modeled as a random variable. This assertion was
made in 1960 by the economist Marschak, who thereby
introduced Thurstone’s work into economics. Marschak called
his model the random utility maximization hypothesis or RUM
[43,44]. Like neoclassical economic theory, the RUM assumes that
the decision-maker has a perfect discrimination capability. But it
also assumes that the analyst has incomplete information, which
implies that uncertainty (i.e., randomness) must be taken into
account.
Multinomial model. Another way to analyze comparative
data is with the Bradley-Terry-Luce (BTL) model, which was
statistically formulated by Bradley and Terry in 1955 [45] and
extended by Luce in 1959 [28] (Later it was recognized that the
German mathematician Ernst Zermelo had already published
about a probabilistic paired comparison model [46]). The BTL
models extends the Thurstone model by allowing a person to
choose among more than two options. It postulates that
measurement on a ratio scale level can be established if the data
satisfy certain structural assumptions [47]. For mathematical
reasons the BTL model is based on the simple logistic function
instead of the normal distribution of the Thurstone model. It is this
mathematical model that McFadden used to develop and
construct his own specific type of multinomial logit model. If only
pairs of alternatives are judged, the BTL model is nearly identical
to Thurstone’s model. However, when more than two alternatives
are judged, an important mathematical assumption must be made,
namely the independence of irrelevant alternatives (see below).
Drawing upon the work of Thurstone, Luce, Marschak, and
Lancaster [48], McFadden was able to show how his model fit in
with the economic theory of choice behavior. McFadden then
investigated further the RUM foundations of the conditional
multinomial logistic model. He showed that the Luce model was
consistent with the RUM model with IID (independent and
identically distributed random variables) additive disturbances if
and only if these disturbances had a distribution called extreme
value type I. More importantly, instead of one function, as in the
classical Thurstone model (only values for health states can be
estimated), the conditional multinomial logistic model comprises
two functions. First, it contains a statistical model that describes
the probability of ranking a particular health state higher than
another, given the (unobserved) value associated with each health
state. Secondly, it contains a valuation function that relates the
value for a given health state to a set of explanatory variables (it
will be shown that the same holds for the MAPR model).
Assumptions. Multinomial logistic regression (MNL) is based
on three assumptions: (i) independence of irrelevant alternatives
(IIA); (ii) error terms are independent and identically distributed
across observations (IID); and (iii) no taste heterogeneity (i.e.,
homogeneous preferences across respondents). Luce’s choice
axiom states that the probability of selecting one item over
another from a pool of many items is not affected by the presence
or absence of other items in the pool (IIA assumption). The axiom
states that if A is preferred to B out of the choice set {A, B}, then
introducing a third, irrelevant, alternative X (thus expanding the
choice set to {A, B, X}) should not make B preferred to A. In other
words, whether A or B is better should not be changed by the
availability of X. The IIA axiom simplifies experimental collection
of choice data by allowing multinomial choice probabilities to be
inferred from binomial choice experiments. It is clear that
assumptions i and iii bear some relation to the invariance principle
from measurement theory.
Mathematics
In conditional logistic regression, none, some, or all of the
observations in a choice set may be marked. McFadden’s choice
model (discrete choice) is thus a special case of multinomial logistic
regression. In the conditional logit (CL) model, the explanatory
variables assume different values for each alternative and the
impact of level changes is assumed to be constant across
alternatives. The model may be summarized as shown below
(Formula 4):
vrs~zrs ª ð4Þ
whereby v are latent values or utilities of individuals choosing
health state s, zrs indicates a vector of alternative-specific explanatory
variables for individual r, and c represents a single vector of
unknown regression coefficients. Under the assumptions described



















where, K (one k has to be set as reference) is the number of
alternatives (e.g., health states) in the choice set (e.g., 2 in most DC
applications) and s is the chosen alternative.
The term multinomial logit (MNL) model refers to a model that
generalizes logistic regression by allowing more than two discrete
outcomes. It assumes that data are case-specific; that is, each
independent variable has a single value for each case. Consider an
individual choosing among K alternatives in a choice set. Let xr
represent the characteristics of individual r and bs the regression
parameters.
~vrs~xrbs ð6Þ







Both models can be used to analyze an individual’s choice
among a set of K alternatives. The main difference between the
two is that the conventional MNL model focuses on the individual
as the unit of analysis and takes the individual’s characteristics as
explanatory variables. The CL model, in contrast, focuses on the
set of alternatives for each individual, while the explanatory
variables are characteristics of those alternatives.
It is possible to combine these two models. Doing so would
simultaneously take into account the characteristics of both the
alternatives and the individual characteristics, using them as
explanatory variables. This combination is sometimes called a
conditional MNL or mixed model:
~~vrs~xrbsz zrsª: ð8Þ
Where ~~vrs is the value of the alternative s assigned by the
individual r. That value (~~vrs) depends on both the alternative
characteristics x and on the individuals’ characteristics z. The







The most commonly applied types of DC models are presented
above. A clear distinction is made between models that take an
individual’s characteristics as explanatory variables (MNL) and
models with explanatory variables for characteristics of alternatives
(i.e., health states). In the next section the Rasch model will be
explained. It will be shown that this model has a close similarity to
the CL model (Equation 5). As the basic data structure underlying
the Rasch measurement model should meet the invariance
assumption (see ‘measurement principles’), this rules out incorpo-
rating elements of the MNL model (Equation 6–9).
Rasch Model
Background
The Rasch model – named after the Danish mathematician,
statistician, and psychometrician Georg Rasch (1901–1980) – is a
probabilistic measurement model. While primarily employed in
attainment assessment, it is increasingly used in other areas [49].
Its original setting was the field of reading skills, where it was
intended for dichotomous response data (e.g., right/wrong). The
field of health outcomes research has shown considerable interest
in the topic of Rasch modeling. Recently, attempts have been
made to apply the Rasch model to specific HRQoL domains (e.g.,
pain, depression, mobility) [50,51].
Rasch did not start from real data but rather from an axiomatic
definition of measurement. He formulated a ‘model’, i.e., an
equation, fixing the ‘ideal’ relationship between the observation
and the amount of the latent trait (i.e., variables that are not
directly observed but are inferred, such as utility). At least three
features of this relationship should be highlighted. First, the
observed response (e.g., pass/yes/agree/right = l, rather than fail/
no/disagree/wrong = 0) depends on the difference between only
two parameters, the ‘ability’ of the individual and the ‘difficulty’ of
the item. No extraneous factors should bias this linear relationship.
Second, ‘ability’ and ‘difficulty’ are independent of each other. As
stated before, this invariance principle is also a theoretical
requirement for measurement in the realm of physics. In his
‘separability theorem’, Rasch demonstrated that his model is the
only one that satisfies this requirement. Third, the model is
probabilistic: uncertainty surrounds the expected response, which
is consistent with the real world situation.
A key element of the Rasch model is that the goal is to construct
procedures or operations that provide data that meet the relevant
criteria [52]. It should be noted that the Rasch model makes
relatively strong assumptions. Nonetheless, if the assumptions hold
sufficiently, this measurement model can produce scales (i.e.,
health-state values) offering a number of advantages over those
derived by standard measurement techniques or even contempo-
rary DC models.
Rasch developed the model for dichotomous data. He applied it
to response data derived from intelligence and attainment tests,
including data collected by the Danish military [53]. It does not
confront the respondents with a paired comparison task or a
ranking task. Instead, the responses are collected separately
(monadic measurement) for a set of items. Versions of the Rasch
model are particularly common in psychometrics, the field
concerned with the theory and technique of psychological and
educational measurement, where they are known as response
models. The most important claim of the Rasch model is that due
to the mode of collecting response data, in combination with the
conditional estimation procedure, the derived measures comply
with the three important principles: interval level, unidimension-
ality, and invariance. Because it uses a specific mechanism (see
explanation below), the application of the Rasch model is
sometimes referred to as fundamental or objective measurement.
Measurement Model
The Rasch model is a mathematical function that relates the
probability of a (correct) response on an item to characteristics of
the person (e.g., ability) and to characteristics of the item (e.g.,
difficulty). For quantifying health states, this model would relate
the probability of a response on a health state to characteristics of
an individual (e.g., own health status) and to characteristics of
given health states (e.g., severity).
Health Measurement Model
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The data structure required by the Rasch model is identical to
that of another response model, namely Guttmann scaling, which
had been developed independently at an earlier stage [54].
Whereas the Guttmann model is deterministic, the Rasch model is
probabilistic. The key to Rasch scaling is in the analysis. Figure 1
(top) shows the responses of 7 patients on 8 health states (A–H).
Subsequently, this matrix is sorted so that patients who agree that
all health states are preferred over their own health state are listed
at the top, and patients agreeing with fewer are at the bottom. For
patients with equal number of agreements, the health states are
sorted from left to right from states that most agreed to, to states
that fewest agreed to. To obtain the specific structure of the data
for Rasch analysis the respondents (their own health status) must
be distributed over the whole unidimensional scale. Thus, a
sample clustered at only one location on the scale (e.g., all healthy
people) is not conducive to good estimations of the model.
Moreover, the Rasch model can be seen as a practical realization
of conjoint measurement (axiomatic theory for quantification of
multiple rank-based attributes) with an underlying stochastic
structure [55]. For this and other reasons, many scientists consider
the Rasch model as the preeminent means to measure subjective
phenomena ‘objectively’.
Extensions of the Rasch model have been developed indepen-
dently and simultaneously; these are known as item response
theory (IRT) models [56]. The extensions differ from the original
model in the sense that they have a parameter to express the
discrimination of an item (the degree to which the item
discriminates between persons in different regions on the latent
continuum). These IRT models relax to some extent the strict
requirements for responses (e.g., data) posed by the Rasch model.
But IRT models do not possess the specific fundamental
measurement property of the Rasch model and therefore do not
necessarily produce cardinal measures [25,53].
Mathematics
In the Rasch model for dichotomous data, the probability that
the outcome is correct (or that one health state is better than





where hr identifies the health status h of the person, and vs refers to
the state s (In many textbooks, the notation of the Rasch model
and other item response theory models is slightly different). By an
interactive conditional maximum likelihood estimation approach,
an estimate vs – vt is obtained without involvement of h, which is a






The invariance of measurement principle has two implications for
the Rasch model. First, estimates of individual characteristics
(person parameter h; i.e., health status) as measured by the
instrument are comparable regardless of which health states are
included in the instrument. Second, estimates of the position (i.e.,
severity) of the health states (item parameter v) on the scale of the
instrument are comparable regardless of the selection of the
sample of respondents. This is true as long as the sample reflects
the broad spectrum of the scale.
The Multi-Attribute Preference Response Model
By incorporating the key response mechanism of the Rasch
model into the DC framework, a new and advanced health-status
measurement model can be obtained. The strength of the DC
models (their capacity not only to quantify health states but also to
estimate a value function) can be combined with the strength of
the Rasch model (individual patients are given responses to
realistic and understandable health descriptions). In principle, such
a new model should also encompass the desirable measurement
features of the fundamental Rasch model (Figure 2). Moreover, the
specific response mode of the Rasch model (patient’s own health
state versus other related health states) will largely prevent any
adaptation effects. This combination of features from the DC and
the Rasch models is referred to as the multi-attribute preference
response (MAPR) model. Although there are (subtle) differences
between methods from related areas, such as multi-criteria
decision analysis (operations research), multi-attribute choice
models (decision science), discrete choice models (economics),
and the MAPR model, many of the objectives and procedures of
these models are the same [57,58]. However, multi-criteria
decision analysis is essentially focused on optimization, the choice
models are focused on explaining choice behavior, whereas the
MAPR model is focused on measurement (i.e., quantification).
In fact, the Rasch model is closely related to most discrete
choice models and their extensions. What makes the Rasch model
unique is the person parameter (h) [59,60]. When dealing only
with choice sets consisting of two health states (s and t), the left part
of Formula 5a can be expressed even more succinctly. Dividing the
Figure 1. Schematic representation of Guttman/Rasch data
structure. Representation of the raw data (top) and after sorting of the
columns (health states) and the rows (patients) in order to arrive at the
hierarchical Guttman/Rasch data structures (the check mark indicates
that this health state is preferred over the next health state, the cross
mark indicates a misfit) (from: [33]).
doi:10.1371/journal.pone.0079494.g001
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numerator and denominator by the numerator, and recognizing





In this equation it is obvious that the basic formulas for the DC
model and the Rasch model differ in only one parameter. The DC
model requires two parameters, vs and vt. In the Rasch model, one
of these parameters is ‘replaced’ by a parameter, h, that represents
the location of the respondent (Formula 11). Formula 12 can
therefore be rewritten as formula 13. The latter is the basic
formula for the MAPR model, created by adding a parameter, c,





In this model a set of linear restrictions is imposed on the health-
state parameters (v) of the Rasch model as, vrs~zrsc. In another
setting and approached differently Fischer developed a model that
has a close connection with the MAPR model [61,62].
Data Collection
As noted, the Rasch model demands a specific data structure
that is essentially different from that of the DC model. The
implication is that data have to be derived by new and innovative
response tasks. Judgments are required from a heterogeneous
sample of people in various health conditions. This means that
respondents should not be a representative sample of the general
population. Instead, they should be patients who are currently
experiencing one of the health states on the continuum from worst
to best health status. The reason for this can be seen in Figure 3
that shows graphically the judgmental task for the conventional
valuation method TTO (A), the DC task (B), and the MAPR
model (C). For the former two a sample of the general population
has to assess a pool of states, which is done for the TTO state by
state and in the discrete choice task for pairs of states. As the
generally population will mainly consist of healthy people they are
positioned on the right side on the HRQoL scale. In the MAPR
model this is different. Based on the initial classification of their
own health status each individual patient is assessing a pool of
health (in this example only 2) states that are located in the region
of their own HRQoL status. So, patients respond to hypothetical
health states by comparing these health states with their own
health condition. For example: ‘‘Is this health state better than
your own health state?’’ (Figure 4). The conditional (multinomial)
logit model will then become similar to the Rasch model. This will
occur when the following criteria are met: each comparison
consists of two health states, one being the patient’s own state; and
the patient’s own health state is considered as a separate parameter
in the conditional estimation procedure.
The central mechanism in the MAPR model is that the response
task is performed in two distinct stages. First, the classification of
the individual’s health status according to the set of health
attributes generates a value for the description of that state (based
on the underlying value function). In the next step – to which not
all respondents has to continue if the value function has reached a
certain stage of predictive precision – individuals are confronted
with a set of health states that cover the range from severe to mild
or a set of other almost ‘equivalent’ states (see below: pivot designs)
that are compared to their own state that is determined at the first
stage (such a comparison may be more easy than under DC). The
information generated in this part is used to arrive at a more
precise value function. Of course, this iterative mechanism only
operates properly after a large number of individuals have gone
through both stages. So, there is clearly an initiation stage in which
patients are performing the judgmental tasks to feed the statistical
part of the MAPR model. At this stage the value of the health
condition of the patients themselves cannot be (precisely)
estimated. It will take probably 1000 or more patients to conduct
the inception of the MAPR model and arrive at a functional
routine. A relatively large number of respondents is required as the
MAPR model has to estimate health-state parameters and patient
parameters, all based on binary data.
As a first exploration of the MAPR model, we may start with the
most basic variant in which an existing health-status classification
system is used (e.g., EQ-5D). First, patients (representing the whole
continuum from bad to mild health conditions) classify their own
health condition on the basis of the EQ-5D classification. Then
they judge a fixed set (say 20) of EQ-5D health states (representing
the whole continuum from bad to mild states).
Pivot Designs
In standard DC studies, all respondents face the same choice
situations (e.g., pair of health states) or a selection of them. While
this is also possible for the MAPR model, it is not an efficient
approach. Rather than presenting patients with a predetermined
set of health states, it would be better to frame the choice task
within an existing decision context, namely a situation pertaining
to an individual person. This strategy makes use of pivot designs.
First, the respondents classify their own health status according to
a standardized system (e.g., EQ-5D, HUI). Then they are shown
alternatives with attribute levels that deviate slightly from their
own levels. Several approaches for finding efficient pivot designs
have been developed. Upon comparison, the most attractive one
proves to be based on the individual’s responses [63]. Because this
approach entails a separate design for each respondent, it should
also yield the highest efficiency. It is well known that a test item
provides the most information about a respondent when its
severity is roughly the same as that of the person’s health status.
Such an approach requires a computer adaptive testing environ-
Figure 2. Data collection designs and response processes in
measurement models. Schematic representation of the different
data collection designs in combination with the specific response
process of these designs and the appropriate measurement models for
these four combinations (combination of discrete choice model and
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ment (e.g., an internet survey). An efficient design is generated
interactively and is therefore well suited to the proposed MAPR
model for quantifying health states.
Individual Choices of Health Domains
The MAPR model can even be extended to cover a large set of
candidate domains. An individual patient could then select the
ones most relevant to his or her assessment (far more than the
traditional four to nine domains in existing instruments). Recently,
specific solutions (partial profile choice designs) for this situation
have been introduced [64]. In such an extended variant of the
MAPR, the precision of the underlying value function will increase
step by step. The reason is that individuals then use more and
more attributes when comparing their own health status with
other health states. Of course, the overall estimation and
convergence of such a MAPR model requires substantial input
from the patients. At present, many aspects of these partial profile
designs remain to be investigated in more detail, in particular in
the setting of health-state valuation – a challenging task. For
example, one of the elementary assumptions in applying this type
of model is that all the attributes (health domains) that are not part
of individual judgmental tasks are to be set to ‘09 (no value).
Studies in other areas have shown that this assumption does not
always hold [65].
Discussion
This article presents a new measurement approach, the multi-
attribute preference response model (MAPR), to quantify subjec-
tive elements of health. The MAPR model can be considered as an
Figure 3. Judgmental tasks used in measurement methods. Schematic representation of the judgmental task for three health states by:
A = conventional monadic measurement (SG, TTO) by a sample of the general population; B = conventional discrete choice task (paired comparison)
by a sample of the general population; C =multi-attribute preference response model for individual patients (3 patients in this example, each
assessing 2 nearby located health states).
doi:10.1371/journal.pone.0079494.g003
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adaptation of the standard discrete choice model or as an
extension of the standard Rasch model. This paper also shows
that seemingly different models are often very similar. Conven-
tional valuation techniques are known to have many problems,
such as adaptation, discounting, context, reference point, and
other effects [66]. With the MAPR model, unwanted mechanisms
affecting valuations of health states may be largely eliminated.
From a theoretical and practical point of view, both the MAPR
and the DC models are more attractive than TTO and other
conventional valuation techniques. In the MAPR and DC models,
the judgmental task and the analysis are executed within one
unifying framework. This is different for the TTO, where the
valuation technique and the statistical model to estimate a value
function are distinct (e.g., using different regression techniques,
different coding of the parameters). The strength of the DC and
MAPR models is that the derived values relate to one particular
aspect: the attractiveness of a health state. Such measures are not
confounded by aspects such as time preference (duration of time
frame) or the choice for an indifference procedure, nor are there
difficulties in quantifying states worse than dead. It is sometimes
said that, unlike the TTO technique, most of the present choice
models to quantify health states do not specify the duration of the
states. However, as the two states in each pair are rather similar in
these type of studies, including a duration statement would hardly
affect the responses. Furthermore, discrimination is a basic
operation of judgment and a means of generating knowledge.
The core activity of measurement in probabilistic choice models is
to compare two or more entities in such a way that the data yields
compelling information on individuals’ preferences, thereby
imitating choices in daily life.
The Rasch model occupies a special position in the field of
subjective measurement, although mathematically it is closely
related to item response theory. Broadly speaking there are two
general schools of thought, each known for its particular approach.
When the response data satisfy the conditions required by these
mathematical models, the estimates derived from the models are
considered robust. When the data do not fit the chosen model, two
lines of inquiry are possible. In essence, when the data do not fit a
given model, the IRT approach is to find a mathematical model
that best fits the observed item-response data. By contrast, the
Rasch measurement approach is to find data that better fit the
Rasch model. Thus, it follows that proponents of IRT use a family
of item-response models, while proponents of Rasch measurement
use only one model (Rasch model).
A major limitation of the MAPR model, as with any
probabilistic choice model, is that it produces relative positions
of all health states on the latent scale [30,67]. For the estimation of
DALYs and QALYs, however, those values need to be on the
‘dead’– ‘full-health’ scale. If the MAPR model is used to value
health, a way must be found to link the position of ‘dead’ with the
derived values. A similar solution may also be relevant to locate
the position of the best (dominant) health state of a multi-attribute
classification system to ‘full health’. A strategy for rescaling DC
values may be to anchor them on values obtained for the best
health state and for ‘dead’ using other valuation techniques, such
as TTO or SG. However, the rationale for this approach is
unclear. Part of the motivation for adopting probabilistic choice
models as potential candidates to produce health-state values lies
in the limitations of existing valuation techniques. Alternatively,
the judgmental format may be set up in such a way that the
derived health-state values can be related to the value of the state
‘dead’. A simple manner to achieve this seems to involve making
designs in which respondents are presented with at least one bad
health state at a time and asked if they consider it better or worse
than being dead. The procedure has been demonstrated by
McCabe et al. [37] and Salomon [31]. These authors mixed the
state ‘dead’ in with the choice set as a health state, so that a
parameter for the state ‘dead’ is estimated as part of the model. To
investigate whether or not this strategy would produce health-state
values with acceptably low bias, it will be necessary to draw
comparisons with values obtained using alternative measurement
methods. A problem associated with including ‘dead’ as part of the
choice set is that proper estimation of values seems only possible if
almost all respondents consider some health states to be worse
than dead. Otherwise, the estimated parameters of the model are
likely to be biased [68]. Another approach could employ models
that are suitable for dealing with dominant health states (the best
health states in a multi-attribute system) to calibrate the metric
distances in this region [69]. One example would be to apply
multidimensional scaling [70]. In sum, it is hard to say beforehand
which approach to deriving DALY/QALY values that are
anchored to ‘dead’ would produce valuable and effective results
for the MAPR model (DC models have the same problems).
Theoretically competent construction of MAPR models and
subsequent experimentation with these models would therefore
be required to see how these difficulties could be resolved in a
particular situation.
Several elements related to the MAPR model must be
investigated empirically to confirm certain assumptions and
explore potential limitations. In particular, the Guttman/Rasch
structure of the data has to be proven. As the data collection
for the MAPR model is done in patient groups, suboptimal
response data may be resulting from interpretation problems of
the health domains and their levels, from using cognitive
shortcuts, from irrational choice behavior, and other factors.
One of the crucial elements that has to be decided on before
any measurement of health status can take place is the selection
of the health domains to conceptualize health-state descriptions.
An overwhelming number of health-status or HRQoL instru-
ments are available. Each has been developed with a particular
concept in mind, resulting in instruments with a specific depth
(basic or subordinate units of information; for example, physical
function, self-care, bathing) and breadth (e.g., physical function,
emotional function, pain, cognitive ability). However, all current
descriptive and preference-based health-status instruments are
based on a predetermined restricted set of health domains. This
Figure 4. Response task MAPR model. Example of a response task
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common denominator has certain drawbacks. For example, for
some patients or diseases, the predetermined set may miss some
crucial health domains. Extending it to create a very broad set
is not feasible for several reasons, both practical and analytical.
In light of information theory, it is clear that a limited set of
domains may deliver enough detailed information to adequately
describe the health status of a person if these domains are well
selected and reflect the domains most relevant to this specific
person.
Therefore, an advantageous property of the MAPR model is
that it can overcome the limitation of the restricted set of health
domains, which is a drawback of the existing preference-based
health-status systems (e.g., HUI, EQ-5D). In many instances,
these instruments prove to be insensitive or invalid, due to their
restricted and fixed set of health attributes. The MAPR model,
in contrast, can be extended to include a large set (40–120) of
candidate domains from which an individual patient can select
a few (5–7), namely the most relevant ones. A large number of
individual responses would be needed to collect enough data. As
there is no shortage of patients, the estimation part of this
model from a practical point of view is not too challenging [64].
Of course, the statistical routines for such an approach have to
be developed, and ultimately, empirical research must prove the
premise of such an extended MAPR model. An instrument that
shows some resemblance to the measurement strategy of the
MAPR model, in which the content is derived from individual
patients, is the SEIQoL [71]. Although it is not embedded in a
formal measurement model, this instrument permits individuals
to select and value the health domains that are important to
them in their HRQoL assessment. The EuroQol Group is
planning to develop special ‘bolt-ons’ (comprising additional
health attributes) that will be added to the existing five health
attributes of the EuroQol-5D system [72]. Yet, the analytical
integration of these bolt-ons does not seem to be part of an
overarching framework. The Group has indicated that in the
end the maximum number of predetermined attributes will be
seven instead of five.
Existing multi-attribute preference-based health-status systems
are conceptualized as having two stages: one encompasses the
valuation study to derive the value function; the second
comprises an application stage, in which the health status of
individuals is determined. One of the major strengths of the
MAPR model is that it is a continuous process of valuation and
application.
Patients may be regarded as the best judges of their own
health status. Therefore, it is sensible to defend the position that
it is the patient’s judgment that should be elicited. However, it
may be the case that values for health states worked out under
the MAPR model both for patients and a sample of unaffected
members of the general population are rather similar [19].
Otherwise, empirical MAPR head-to-head studies may reveal
that responses from the general population are evenly valid,
except maybe for the very worst health states. These type of
health states may be under or overestimated by healthy people
due to lack of familiarity with the impact of seriously reduced
health.
The MAPR model may also be an avenue for developing a
health-status measurement instrument that can be used in
broader settings (e.g., medical interventions and medical care)
and in distinctive patient populations (e.g., children, adults,
elderly). Another possible extension of the MAPR model would
be to combine it with Monte Carlo simulation and then to use
this technology in estimating response models within a full
Bayesian framework [73,74]. In principle, the MAPR model
may be suitable to measure other unidimensional, subjective
phenomena such as well-being, capabilities, and happiness;
under certain conditions it might be used in social value
judgments (e.g., reimbursement decisions). For the overall
quantification of quality in general the MAPR model may also
be beneficial [75]. Our group is currently working on different
variants of the MAPR model and the related estimation
functions. In addition, the first empirical patient studies are
planned.
Conclusions
Incorporating the basic elements of the Rasch model into the
DC framework (or vice versa) produces an advanced model with
fundamental measurement characteristics: the multi-attribute
preference response (MAPR) model. This new patient-reported
outcome measurement model is more coherent than the
conventional valuation methods and has a profound connection
to measurement theories. The MAPR model can be applied to
a wide range of research problems. Specifically, if extended with
self-selection of relevant health attributes for the individual
patient, this model will be more valid than existing valuation
techniques.
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